From: Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Characteristics | CD8+Foxp3+ | Granzyme B+Foxp3+ | ||||
---|---|---|---|---|---|---|
≤0.90 (n = 53) |
> 0.90 (n = 53) | P |
≤1.80 (n = 54) |
> 1.80 (n = 52) | P | |
Age, years | ||||||
≤49 | 24 | 31 | 26 | 29 | ||
> 49 | 29 | 22 | 0.174 | 28 | 23 | 0.432 |
Gender | ||||||
Male | 39 | 45 | 42 | 42 | ||
Female | 14 | 8 | 0.151 | 12 | 10 | 0.704 |
Tumor (T) stage | ||||||
T1+T2 | 25 | 32 | 29 | 28 | ||
T3+T4 | 28 | 21 | 0.173 | 25 | 24 | 0.988 |
Lymphoid Nodal (N) status | ||||||
N0 | 14 | 4 | 10 | 8 | ||
N1-3 | 39 | 49 | 0.010* | 44 | 44 | 0.866 |
TNM Clinical stage | ||||||
I + II | 18 | 20 | 19 | 19 | ||
III+IVa+IVb | 35 | 33 | 0.685 | 35 | 33 | 0.885 |
LMP1 | ||||||
- | 23 | 33 | 30 | 26 | ||
+ | 27 | 20 | 0.098 | 22 | 25 | 0.494 |